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Abstract: The lytic phage, fHe-Kpn01 was isolated from sewage water using an extended-spectrum
beta-lactamase-producing strain of Klebsiella pneumoniae as a host. The genome is 43,329 bp in size
and contains direct terminal repeats of 222 bp. The genome contains 56 predicted genes, of which proteomics
analysis detected 29 different proteins in purified phage particles. Comparison of fHe-Kpn01 to other
phages, both morphologically and genetically, indicated that the phage belongs to the family Podoviridae
and genus Drulisvirus. Because fHe-Kpn01 is strictly lytic and does not carry any known resistance or
virulence genes, it is suitable for phage therapy. It has, however, a narrow host range since it infected only
three of the 72 tested K. pneumoniae strains, two of which were of capsule type KL62. After annotation
of the predicted genes based on the similarity to genes of known function and proteomics results on
the virion-associated proteins, 22 gene products remained annotated as hypothetical proteins of unknown
function (HPUF). These fHe-Kpn01 HPUFs were screened for their toxicity in Escherichia coli. Three of
the HPUFs, encoded by the genes g10, g22, and g38, were confirmed to be toxic.
Keywords: bacteriophage; Podoviridae; Drulisvirus; hypothetical proteins of unknown function; toxic
proteins; antibiotic resistance; antibiotics; Klebsiella pneumoniae; capsule type
1. Introduction
Infections with antibiotic-resistant bacteria cause 700,000 deaths per year and the number of
fatalities is predicted to drastically increase to 10 million per year by 2050 [1]. Klebsiella pneumoniae is
a rod-shaped bacterium that is responsible for one-third of the infections caused by gram-negative
bacteria. K. pneumoniae isolates constitute a major source of antibiotic resistance that has steadily
increased over the years [2]. Infections with extended-spectrum antibiotic-resistant K. pneumoniae
cause prolonged hospitalization, high mortality, and high economic burden [3]. Antibiotic resistance is
acquired by both accumulating mutations and horizontal gene transfer (HGT) of antibiotic resistance
between bacteria. HGT is the major cause of the development of extremely drug-resistant bacteria [2].
The lack of treatment for infections with multidrug-resistant (MDR) gram-negative bacteria is considered
as the biggest unmet medical need [4]. The World Health Organization listed the carbapenem-resistant
and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae, which include among
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others K. pneumoniae and Escherichia coli, as the critical pathogens for which new antibiotics should be
developed [5]. Treating infections of MDR bacteria with phage therapy may be one of the treatment
options, although most phages have a very narrow host range, which makes finding the right
bacteriophage a challenge [6,7]. The development of new antibiotics is therefore still believed to be
the most promising solution to tackle resistant bacteria [4].
Promising novel antibiotics may be developed from phage proteins. Phage endolysins,
virion-associated peptidoglycan hydrolases, polysaccharide depolymerases, and holins are already
extensively studied for their use as antibiotics. Phages use these enzymes to infect or lyse bacteria [8].
Many more bacteriophage proteins specifically interact with bacterial proteins to ensure an efficient
infection cycle. Interestingly, the functional mechanisms of these interactions are largely unknown [9].
Furthermore, 70% of the predicted genes in phage genomes are annotated to encode for hypothetical
proteins of unknown function (HPUFs) [10–12]. The HPUFs mostly encode small proteins ranging
from 30 to 200 amino acids. The great potential of using HPUFs as toxic proteins has already been
shown [13–17]. The HPUFs may be toxic via yet unknown mechanisms and have the potential to be
developed into innovative antimicrobial peptides.
Here, we describe the isolation and characterization of phage fHe-Kpn01 that infects an ESBL
strain of K. pneumoniae. A systematic screen of the HPUFs present in the genome of fHe-Kpn01
revealed the presence of three proteins that are toxic to E. coli, providing new leads for developing
innovative antibiotics.
2. Materials and Methods
2.1. Bacterial Strains, Phage, and Media
E. coli laboratory strain DH10B [18] was used for routine plasmid DNA isolation and cloning.
E. coli DH5α [19] was used in the experiment to confirm protein toxicity. Electrocompetent cells for
E. coli were prepared, stored, and used as described previously [20]. The K. pneumoniae strains used in
this work are described in Table S1 and were mostly obtained from the hospital district of Helsinki
and Uusimaa laboratories (HUSLAB), Finland. Media (agar, tryptone, tryptone soy broth, yeast extract)
were purchased from Neogen Food Safety, Lansing, MI, USA. Unless indicated otherwise, bacterial
and phage incubations were performed at 37 ◦C using Luria Broth (LB) [21]. Soft agar LB medium
included additionally 0.4% (w/v) agar and LB agar plates were solidified with 1.5% (w/v) of agar. M9t
minimal medium contained 3.4 mM Na2HPO4, 2.2 mM KH2PO4, 0.86 mM NaCl, 0.94 mM NH4Cl,
0.2% (w/v) tryptone, 2.0 mM MgSO4, 0.10 mM CaCl2 and 3.0 × 10−3 mM vitamin B1 (Merck KGaA,
Darmstadt, Germany). Bacterial strains were stored at −80 ◦C in 3% (w/v) tryptone soy broth with 20%
(v/v) glycerol. Phage fHe-Kpn01 was stored at −80 ◦C in LB supplemented with 8% dimethyl sulfoxide.
2.2. Phage Isolation and Purification
fHe-Kpn01 was isolated from a municipal sewage sample collected in Helsinki, Finland, using
clinical ESBL K. pneumoniae strain #5504 (Table S1) as the host. The same strain was used as the standard
host strain for the phage. Phage lysates were produced from semiconfluent soft-agar plates as described
elsewhere [21]. The fHe-Kpn01 lysate was ultrafiltrated with Amicon Ultra-4 (100 kDa) centrifugal
filter units (Merck KGaA, Darmstadt, Germany) to one-quarter of the initial volume. Three volumes of
SM buffer (100 mM NaCl, 50 mM Tris pH 7.5, 10 mM Mg2SO4, 0.01% (w/v) gelatin (Type B from bovine
skin, Merck KGaA, Darmstadt, Germany)) were added and ultrafiltration was repeated. The phages
were purified further by discontinuous glycerol density gradient ultracentrifugation at 40,000 rpm
at 4 ◦C for 4 h in a Beckmann Coulter SW55Ti swing-out rotor. The phages were resuspended after
ultracentrifugation in SM buffer containing 8% (w/v) sucrose. Purified phage particles and intermediate
purification products were stored at 4 ◦C.
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2.3. Electron Microscopy
Ultra-centrifuged phage particles were sedimented by centrifugation at 16,000× g at 4 ◦C for 2 h
and resuspended in 0.1 M ammonium acetate, pH 7.2. Subsequently, the phage particles were allowed
to sediment on 200 mesh Formvar-coated copper grids for 1 min and stained negatively using 1%
uranyl acetate pH 4.2 (method modified from [22]). Stained particles were observed using a JEOL
JEM1400 electron microscope operated at 80 kV at the Department of Virology, University of Helsinki.
Pictures were taken using an Olympus Morada CCD camera.
2.4. Host Range Determination
The host range of fHe-Kpn01 was determined by pipetting droplets of 10 µL of serial dilutions
of concentrated phage stocks on lawns of different bacterial strains prepared on LB agar plates.
72 K. pneumoniae strains, one K. oxytoca, and one E. coli strain (negative control) were used (Table S1).
The plating efficiency, measured by the formation of plaques of lysis, was tested at 37 ◦C. Positive droplet
test results were confirmed by the double-layer method using appropriately diluted phage preparations.
2.5. Infection Growth Curves
An overnight bacterial culture of K. pneumoniae #5504 was diluted 100-fold in fresh LB medium
and 270-µL aliquots were distributed into Bioscreen Honeycomb 2 plates wells (Growth Curves Ab Ltd.,
Helsinki, Finland), where they were mixed with 30 µL of different fHe-Kpn01 phage stock dilutions.
The phage stock and bacterial culture were mixed to achieve multiplicity of infection (MOI) values
ranging between 10−6 and 10−2. The control consisted of 270 µL of bacterial culture and 30 µL of fresh
LB medium. The growth experiment was carried out at 37 ◦C using a Bioscreen C incubator (Growth
Curves Ab Ltd., Helsinki, Finland) with continuous shaking. The optical density at 600 nm (OD600)
of the cultures was measured every hour for up to 15 h. The averages were calculated from values
obtained for the bacteria grown in five parallel wells.
An overnight bacterial culture of K. pneumoniae #6326 was diluted to a ratio of 1:10 in fresh
LB medium, and 180-µL aliquots were distributed into Bioscreen Honeycomb 2 plates wells, where
they were mixed with 20-µL aliquots of different fHe-Kpn01 phage stock dilutions. The phage stock
and bacterial culture were mixed to achieve MOI values ranging between 10−6 and 10−2. The control
consisted of 180 µL of bacterial culture and 20 µL of fresh LB medium. The growth experiment was
carried out at 37 ◦C using a Bioscreen C incubator with continuous shaking. The OD600 of the cultures
was measured every 45 min for up to 15 h. The average values were calculated from values obtained
for the bacteria grown in four parallel wells.
2.6. Genome Sequencing and Analysis
Phage DNA was obtained from high-titer phage preparations as described earlier [21] or using
the Invisorb Spin Virus DNA Mini Kit (Stratec Biomedical, Birkenfeld, Germany). Sequencing was
performed at Eurofins Genomics. The next-generation sequencing DNA library (insert size of 665 ± 370
nucleotides) was paired-end sequenced using Illumina MiSeq sequencer (Illumina, San Diego, CA, USA)
with a read length of 150 nucleotides. The A5 (Andrew And Aaron’s Awesome Assembly)-miseq
integrated pipeline for de novo assembly of microbial genomes was used to assemble the genome
sequence [23]. The termini of the phage genome were identified using PhageTerm [24], restriction
digestions and Sanger sequencing using phage DNA as template and the fliC fragment ligation
approach [25]. The orientation of the genome was arranged similarly to the sequences of closely related
homologs as found in a nucleotide BLAST search. The genes were annotated with RAST software [26]
and validated manually confirming also that the predicted genes were accompanied by a properly
located ribosomal binding site.
A protein BLAST against the non-redundant protein sequences database (release 2.9.0 from April 1,
2019) was performed for every predicted gene product and the two results with the lowest E-values were
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recorded (Table S2). Furthermore, every gene product was analyzed using HHpred [27] and the best hits
with a probability above 50% and an E-value below 1 were recorded (Table S2). The presence of tRNAs
was investigated using tRNAscan-SE [28]. In addition, Res-Finder-3.1 [29] and VirulenceFinder-2.0 [30]
software was used. The protein content, as tryptic peptides, of purified phages was analyzed using
liquid chromatography-tandem mass spectrometry (LC-MS/MS) at the Proteomics Unit, Institute of
Biotechnology, University of Helsinki as described earlier [17,31]. Calibrated tryptic peptide peaks
were searched against the predicted tryptic peptides from the amino acid sequences of all open reading
frames (ORFs), even the non-annotated ones, in the genome of fHe-Kpn01. The proteins identified by
LC-MS/MS analysis as having two or more unique tryptic peptides and over 5% sequence coverage
were annotated as phage (structural) proteins. The complete genome sequence with annotation was
deposited in the NCBI nucleotide database (GenBank) under accession number MN380459.
Bacterial genomic DNA from K. pneumoniae strains #5504 and #6326 was isolated from a 5-mL
overnight culture using the NucleoSpin Microbial DNA Kit (Macherey-Nagel, GmbH Düren, Germany)
following the manufacturer’s instructions. Sequencing was performed at Novogene Europe (Cambridge,
United Kingdom) using Illumina HiSeq with 150-bp paired-end reads. The genomic scaffolds of
the strains were assembled de novo from the raw Illumina reads with SPAdes genome assembler
v3.14.0 [32]. The genome sequences of K. pneumoniae strains ATCC 10031, ATCC 43816, and ATCC
700721 were retrieved from the ATCC Genomes database. Multi-locus sequence types and the K
(capsule) and O antigen (lipopolysaccharide, LPS) serotypes of the K. pneumoniae strains were predicted
using Kleborate tool [33,34]. The raw sequence read data of K. pneumoniae strains #5504 and #6326 was
deposited to the NCBI sequence read archive under bioproject PRJNA627626.
2.7. Restriction Fragment Analysis of Phage DNA
Restriction digestions of purified fHe-Kpn01 DNA were performed with restriction endonucleases
BamHI, BoxI, ClaI, NotI, NsiI (Thermo Fisher Scientific, USA), Acc65I, DraI, MscI, and SalI-HF
(New England Biolabs, Ipswich, MA, USA) in appropriate digestion buffers.
2.8. Detection of Nicks in the Phage DNA
To detect nicks in the genome of fHe-Kpn01, approximately 300 ng of purified fHe-Kpn01
genomic DNA was incubated for 30 min at RT with 200 U S1 nuclease (Thermo Fisher Scientific, USA)
in the supplied reaction buffer.
2.9. Phylogenetic Analysis
A nucleotide BLAST search of the complete genome of fHe-Kpn01 against the nucleotide collection
(nr/nt) database with optimized conditions for highly similar sequences was used to detect the phages
that are most closely related to fHe-Kpn01. A phylogenetic tree was created using fHe-Kpn01,
all drulisviruses present in the ICTV virus taxonomy (release 2018b) [35], and the type species
of the other subfamilies present in the family Autographivirinae with more than one species per
subfamily. The genome-BLAST distance phylogeny (GBDP) method [36] with settings appropriate
for prokaryotic viruses [37] was used to conduct pairwise comparisons of the nucleotide sequences.
The obtained intergenomic distances were used to create a balanced minimum evolution tree with
branch support inferred from 100 pseudo-bootstrap replicates each. The tree was created via FASTME
with subtree pruning and regrafting postprocessing [38] using the formula D0. Rooting was performed
at the midpoint [39] and the tree was visualized using FigTree [40]. Taxon boundaries at the family,
genus, and species level were assessed using the OPTSIL program [41], the favored clustering
thresholds [37], and an F value (fraction of links required for cluster fusion) of 0.5 [42].
2.10. Initial Screening of HPUFs for Toxicity
Toxic and non-toxic control genes and fHe-Kpn01 genes of HPUFs were cloned into the multiple
cloning site of a pUC19-based vector pU11L4 [17] using a three times molar excess of the insert. Cloning
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was performed using the NotI and NcoI restriction sites (Thermo Fisher Scientific, USA). Whenever
an internal NcoI site was present in one of the genes, NheI (Thermo Fisher Scientific, USA) digestion was
used instead (Table S3). RegB, a restriction endoribonuclease from phage T4 [43] was used as the toxic
control. As non-toxic control, the structural phage capsid vertex protein gene product 178 (Gp178)
from phage ϕR1-RT [17,44] was used. Electrocompetent DH10B E. coli cells with a transformation
efficiency between 108 and 109 colony forming units (CFUs) per µg of intact pU11L4 plasmid (5387 bp
in size) were used. Preparation of the electroporation mixtures and melting of electrocompetent cells
was performed on ice. Ligation mixtures, containing the equivalent of 10 ng vector backbone, were
directly electroporated into 45 µL of electrocompetent DH10B E. coli. Electroporation was performed
in 2 mm electroporation cuvettes (Bulldog Bio, Portsmouth, NH, USA) and a pulse was given using
a Gene Pulser II in combination with a Pulse Controller Plus (Bio-Rad Laboratories, USA) set at 200 Ω,
25 µF and 2.5 kV. Immediately after giving the pulse, the cells were transferred to 950 µL SOC medium
(2% (w/v) tryptone, 0.5% (w/v) yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4,
20 mM glucose) and incubated at 35 ◦C while shaking vigorously. After one hour, an appropriate
amount (25–50 µL) of transformed cells was plated in triplicate on LB agar plates supplemented with
100 µg/mL ampicillin (Merck KGaA, Darmstadt, Germany). The plates were incubated overnight
at 37 ◦C and the CFUs per transformation were determined by counting the number of colonies
the following day. In general, in each experiment, six fHe-Kpn01 genes were tested simultaneously
with the two control genes. The CFUs were standardized to the CFU of the g178 gene in an individual
experiment. Two biological replicates of each fHe-Kpn01 gene were used for electroporation.
2.11. Confirmation of Protein Toxicity
Genes of potentially toxic fHe-Kpn01 HPUFs (selected in the initial screening assay) and negative
and positive controls regB and g178 were cloned into the pBAD33 vector [45] using KpnI and XbaI
(Thermo Fisher Scientific, USA). Cloning was performed with SphI when there was an internal XbaI
restriction site (Thermo Fisher Scientific, USA). After plasmid purification, the presence of the correct
inserts was confirmed by sequencing at the Institute for Molecular Medicine Finland Technology
Centre Sequencing Unit [46]. Three single colonies per gene (plasmids in DH5α E. coli) were inoculated
in LB medium (1.5 mL) supplemented with 20 µg/mL chloramphenicol (Clm, Merck KGaA, Darmstadt,
Germany) and 0.2% (w/v) glucose in 15 mL centrifuge tubes. The tubes were incubated overnight
at 37 ◦C while shaking vigorously. Afterward, the bacteria were washed by centrifuging for 5 min
(3100× g) and replacing the medium with 1.5 mL M9t medium. Then, M9t medium supplemented
with 20 µg/mL Clm and either 0.2% (w/v) glucose or 0.2% (w/v) arabinose was inoculated with 1%
inoculum. The solutions were transferred in triplicate (300 µL/well) to Bioscreen Honeycomb 2 plates.
The OD600 was measured every hour for 20 h using the Bioscreen C MBR (Oy Growth Curves Ab
Ltd, Helsinki, Finland). The plate was shaken continuously with normal speed and high amplitude,
shaking was stopped 5 sec before measuring, and measuring was started immediately. The overall
mean values and standard deviations were calculated over the three biological replicates.
2.12. Prediction of the Structure of Toxic Proteins
The structures of the toxic proteins were modeled using Phyre2 [47].
3. Results
3.1. General Genomic Features of fHe-Kpn01
Phage fHe-Kpn01 was isolated from a municipal sewage sample collected in Helsinki, Finland.
The genome sequence was assembled using 250,000 reads with an average whole-genome coverage
of 827 x. The length of the genome is 43,329 bp with a GC-content of 53.6%. Direct terminal repeats
of 222 bp are present on both ends of the genome. The genome was digested by at least eight
endonucleases (Figure S1), which indicates that the genome consists of unmodified double-stranded
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DNA. The approximate termini of the genome were determined by restriction enzyme digestion
analysis (Figure S1) and comparison of the genome to similar phages (Figure 1). The exact termini were
determined using the PhageTerm tool [24] and the fliC fragment ligation approach (Figure S2) [25].
The ligation experiments and Sanger sequencing confirmed that the termini are blunt. In the PhageTerm
analysis, in addition to the read coverage peaks of the physical termini of the genome, a third major
peak at nucleotide position 7873 with high read coverage was detected (Figure S3). The third peak is
most likely due to a nick in the genome, since fragments of the expected size were generated when
the genome was digested with an S1 nuclease that recognizes single-stranded DNA (Figure S3).Viruses 2020, 12, x FOR PEER REVIEW 7 of 17 
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Figure 1. Alignment of the fHe-Kpn01 genome with the closest related phage vB_KpnP_SU503 (NC_028816;
43,809 bp) and KP34 (NC_013649: 43,809 bp), the type phage of the drulisviruses. The genes are represented
by yellow arrows. A green area in the consensus identity indicates high similarity and a red area indicates low
similarity between the three phages. Generated with Geneious v11.1.5 [50].
The fHe-Kpn01 genome contains 56 predicted genes that occupy 94.0% of the whole coding
capacity. The predicted genes only occur in the forward orientation and encode proteins ranging from
38 to 1232 amino acids in size. An ATG start codon was used for 52 genes, while the remaining four
genes started with a TTG start codon. An overview of the predicted proteins, the length of the proteins,
and the closest homologs is presented in Table S2. LC-MS/MS analysis confirmed the presence of 29
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proteins in phage particles (Table S2) which can be considered as phage particle associated proteins
(PPAPs) as some of them are clearly structural and some are just carried over to function early in
infection. No tRNAs genes were found in the genome. Additionally, no known genes encoding
integrases, lysogeny- or virulence-associated proteins, or acquired antimicrobial resistance genes were
identified and therefore this bacteriophage can be considered as virulent and potentially safe for
phage therapy.
3.2. Comparison of fHe-Kpn01 to Closely Related Phages
The genome size (43 kb), size of the icosahedral capsid (59 nm), and the short tail (Figure S4) of
fHe-Kpn01 are typical characteristics of a podovirus. Moreover, the closest related phage to fHe-Kpn01
is the Klebsiella phage vB_KpnP_SU503, a phage in the family Podoviridae, subfamily Autographivirinae,
and genus Drulisvirus [48]. A 96.5% overall nucleotide identity, with 95% query coverage, was found
between the phages. Comparison of the genomes of fHe-Kpn01, vB_KpnP_SU503, and KP34 [49],
the type species of the drulisviruses, reveals that the genomic organization is very similar in all
three phages (Figure 1). Furthermore, a lysis gene cluster consisting consecutively of genes encoding
a spanin, a holin, and an endolysin was identified in both fHe-Kpn01 (genes g54-g56, Table S2) and other
drulisviruses [48]. Phylogenetic comparison of fHe-Kpn01, nine drulisviruses and six other phages
in the family Autographivirinae generated the tree as shown in Figure 2, with an average support of
38%. The OPTSIL clustering yielded sixteen species clusters, six genus clusters, and one family cluster.
Phage fHe-Kpn01 groups with the other drulisviruses in the phylogenetic tree. We suggest classifying
fHe-Kpn01 in the family Podoviridae, subfamily Autographivirinae, and the genus Drulisvirus.
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Figure 2. The phylogenetic genome-BLAST distance phylogeny (GBDP) tree of fHe-Kpn01, the drulisviruses
present in the ICTV virus taxonomy (release 2018b) [35], and the type species of other subfamilies present
in the family Autographivirinae. The numbers above branches are GBDP pseudo-bootstrap support values
(100 replications). The branch lengths are scaled in terms of the used formula D0.
3.3. fHe-Kpn01 Host Range and Growth Characteristics
Host range experiments revealed that fHe-Kpn01 has a narrow host range as it was able to
infect only three of the 72 tested (mostly) clinical strains of K. pneumoniae (Table S1). The strain
used for isolation of the phage (#5504, an ESBL K. pneumoniae strain) and strain #6326 [51] were
efficiently infected. The phage formed round clear 4–5 mm diameter plaques with haloes on strain
#5504 (Figure S5). Strain #5529 is ampicillin-resistant and was only infected by fHe-Kpn01 with
very low efficiency. While the capsular serotype of strain #5529 is not known, the capsular serotype
of the fHe-Kpn01 sensitive strains #5504 and #6326 was predicted to be KL62 based on the whole
genome sequence data (Table S4). On the other hand, the known capsular serotypes of some of
the phage-resistant strains were KL1, KL2, KL49, KL64, or KL107 (Table S4). We conclude that
fHe-Kpn01 should be classified as a KL62 specific phage.
To examine the efficiency of fHe-Kpn01 infection, K. pneumoniae strains #5504 and #6326 were
infected in liquid culture at different MOI values and the bacterial growth was assessed. The study
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showed that fHe-Kpn01 can efficiently lyse both cultures at MOIs of at least 10−6 (Figure 3). However,
re-growth of the bacterial culture was observed within the 15 h period of the experiment, indicating
the presence of phage-resistant bacteria. In coherence, the prolonged incubation of bacteria infected
with fHe-Kpn01 in soft agar resulted in the emergence of resistant bacteria within two days of
incubation, indicating a relatively high rate of phage-resistance development among the bacteria.
This phenomenon is in contrast to the low rate of phage-resistance development seen with Twort-like
phages [31]. It could be a common feature for podoviruses as we have observed it with some of our
yersiniophages or as a common property of Klebsiella as observed previously by Tan et al. [52].
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Bacteria were cultured with different initial multiplicities of infections (MOIs) in liquid LB-medium
at 37 ◦C. Each data point represents the average optical density (OD) at 600 nm for four to five replicates
and error bars represent the standard deviation (SD).
3.4. Antibacterial Potential of fHe-Kpn01
On average two-thirds of the predicted gene products of newly sequenced phage genomes
are an otated as HPUFs [10–12], among which some are f u d to possess toxic properties [13–17].
Bioinformatic analysis (BLASTP) assigned a predicted function t only 22 out of 56 gene products of
fHe-Kpn01, so 34 were annotated as HPUFs. To exclude viri -associated (likely non-toxic) proteins
from the HPUFs, LC-MS/MS analysis of purified phage particles was carried out. Among the altogether
29 virion-associated proteins (Table S2) were 12 HPUFs that were excluded from further toxicity
screening. Thus, 22 true HPUFs remained to be included in the toxicity screen (Table S3).
We systematically screened all HPUFs by cloning each PCR-amplified HPUF-gene into the pU11L4
plasmid. The resulting ligation mixtures as such were electroporated into E. coli DH10B. Bacteria were
spread onto LB agar plates and the amount of CFUs was counted on the following day. The CFUs
relative to the CFU of the non-toxic control Gp178 are displayed in Figure 4 (details in Table S5).
The cloning of the toxic control gene regB resulted in a significantly lower number of transformants (6%)
than the non-toxic control gene g178. Interestingly, among the 22 HPUFs of fHe-Kpn01, the number of
transformants varied and five HPUF genes, g10, g22, g23, g35, and g38, with the lowest ratios relative
to g178 (below 0.4 with a maximum SD of 0.15), were considered to encode potentially toxic proteins.
3.5. Three Toxic Proteins are Encoded in the Genome of fHe-Kpn01
The initial screening assay was performed with crude ligation mixtures. Therefore, the numbers of
transformants could be affected by the presence of unwanted ligation products, possibly reflected in
the relatively high variation between the replicates (Figure 4). To confirm the toxicity of the five selected
potentially toxic proteins, their genes were cloned into the pBAD33 plasmid under an arabinose-inducible
promoter and transformed into E. coli DH5α. When grown in minimal medium supplemented with
arabinose, the genes cloned into pBAD33 are expressed, while expression is inhibited in the presence
of glucose. As a consequence, the growth curves of bacteria carrying a toxic gene should differ in
the presence of either glucose or arabinose, while for bacteria containing a non-toxic gene the growth
curves should be identical. Figure 5A shows similar growth curves for all transformed bacteria in
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the presence of glucose, except for the bacteria containing the toxic control gene regB, which grow
slightly more slowly. This could be due to partial leakage of the glucose-repression. On the other hand,
the growth curves in the presence of arabinose reveal clear toxic effects, in addition to RegB, for Gp10,
Gp22, and Gp38, while Gp23 and Gp35 appear to be non-toxic. (Figure 5B). Therefore, we conclude that
Gp10, Gp22, and Gp38 of fHe-Kpn01 demonstrate toxicity in E. coli.
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Figure 4. Toxic gene screening by transformation efficiency plating showing the average number
of colony forming units (CFU) of transformants (± SD of two biological replicates) relative to that
of g178. The ligation mixtures of the pU11L4 backbone with the hypothetical proteins of unknown
function (HPUF) genes of fHe-Kpn01 or the control genes regB (toxic, a restriction endoribonuclease
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mixture, the number of transformants was determined from triplicate plating. The cut-off value for
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3.6. The Structure of Gp22 Resembles Nucleotidyltransferases
Gp10, Gp22, and Gp38 of fHe-Kpn01 are predicted to be proteins of 69, 182, and 146 amino
acids in size, respectively (Table S2). To get an idea of the possible functions and mechanisms of
toxicity of these proteins, the protein sequences were analyzed by HHpred [27] and the structures of
the proteins were modeled using Phyre2 [47]. No similar proteins or structures were found for Gp10
by either HHpred or Phyre2. For Gp38, HHpred indicated resemblance with an N-acetyltransferase
with a probability of 97.7% and an E-value of 0.0044 (Table S2), but no structure was predicted
by Phyre2. Gp22 was predicted to resemble a nucleotidyltransferase by both Phyre2 and HHpred
Viruses 2020, 12, 544 10 of 16
with over 90% confidence, 73% sequence coverage, and at most 29% amino acid identity by Phyre2
and a probability of 99.8% and E-value of 3.3 × 10−19 in HHpred. The closest related structures to
that of Gp22 were nucleotidyltransferases of Aquifex aeolicus [53,54], human mitochondria [55,56],
Bacillus stearothermophilus [57], Thermotoga maritima [58], E. coli [59], and Planococcus halocryophilus [60].
4. Discussion
We here describe the isolation and characterization of Klebsiella phage fHe-Kpn01. The 43,329 bp
genome has direct 222 bp terminal repeats and contains 56 predicted genes, all in the forward
orientation (Figure 1, Table S2). The capsid diameter was determined to be 59 nm and the phage
has a short tail (Figure S4). The closest homolog to fHe-Kpn01 is Klebsiella phage vB_KpnP_SU503
and fHe-Kpn01 is classified in the family Podoviridae, subfamily Autographivirinae, and the genus
Drulisvirus. The combined results of the restriction analysis of the genome (Figure S1), Sanger
sequencing (Figure S2), comparison of the genome to closely related phages (Figure 2), and PhageTerm
analysis [24] (Figure S3) confirmed the location of the physical termini and the 222 bp direct terminal
repeats in the genome of fHe-Kpn01. The presence of a third peak in the output of PhageTerm
was noticed, besides the two peaks indicating the termini of the genome (Figure S3). An excess of
sequencing reads was previously used as an indicator for localized single-stranded interruptions, also
known as nicks, in the genome of some podoviruses [61,62] and siphovirus PR1 [63]. The DNA library
of fHe-Kpn01, which was used for the sequencing of the phage genome, was prepared by mechanical
shearing of the DNA. Nicks in the genome are prone to mechanical shearing and therefore a majority of
the DNA molecules could break at this specific location during the preparation of the library. Treatment
of the fHe-Kpn01 genomic DNA with S1 nuclease, a nuclease that recognizes single-stranded DNA,
indeed indicated the presence of a nick in the genome of fHe-Kpn01, which probably corresponds
to nucleotide position 7873 as indicated by PhageTerm (Figure S3). A nick in the genome is also
observed in, among others, siphoviruses T5 [64] and BF23 [65], and podoviruses tf [66], ϕkF77 [67]
and LIMElight [68]. Since nicks are present in the genome of several phages, it is important to have
a critical look at the output generated by PhageTerm, especially when multiple peaks are present, to
prevent an incorrect annotation of the genomic termini.
Initially, fHe-Kpn01 was isolated for usage in phage therapy. Indeed, fHe-Kpn01 is suitable to
use in phage therapy since it is a lytic phage and does not encode any known bacterial virulence or
antibiotic resistance genes. The host range of fHe-Kpn01 is narrow and therefore the application of this
phage in phage therapy would be limited. To elucidate the host specificity of fHe-Kpn01, we sequenced
two of the three fHe-Kpn01 sensitive K. pneumoniae strains (Table S1), #5504 and #6326, and based on
the Kleborate analysis (Table S4) both are predicted to be of capsule type KL62 and O-serotype O1v1.
Since the capsule is the most common receptor for Klebsiella phages, we conclude that fHe-Kpn01
should be classified as a KL62 specific phage. The phage specificity to a bacterial strain depends
on the compatibility of the phage tail fiber receptor binding domain and the receptor structure on
the cell surface [7]. Therefore, major differences are detected between the sequences of receptor binding
proteins (RBPs) in closely related phages with different host ranges, specifically in the receptor binding
domains. Two tail components have been classified as RBPs in KP34viruses, corresponding to Gp49
and Gp57 of fHe-Kpn01 [48,69]. The Gp49 RBP homolog appears to occupy a structural role in the tail
fiber architecture without any role in the host specificity, leaving that role to the Gp57 homolog [48,69].
Phage vB_KpnP_SU503, the closest relative of fHe-Kpn01, is also very likely KL62-specific as its
predicted RBPs, SU503_45 and SU503_53, are 100% and 96.4% identical to Gp49 and Gp57, respectively
(Table S2). Gp57 is a 500 aa protein with only 18 residues that are different from those of SU503_53, with
14 of those scattered in the C-terminal half of the protein (Figure S6). Likely, the N-terminal end of Gp57
contains the pectate lyase enzymatic domain, allowing for degradation of the KL62 capsule [48,69].
Discovering toxic proteins from phages is possible in several ways. First of all, interactions
between known bacterial targets and phage proteins can be investigated. Van den Bossche et al. [15]
used affinity chromatography to find the interacting phage proteins of nine macromolecular complexes
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involved in transcription, DNA replication, fatty acid biosynthesis, RNA regulation, energy metabolism,
and cell division of Pseudomonas aeruginosa. Seven phages (myoviruses, podoviruses, and siphoviruses
with genomes ranging from 42 to 72 kb and one genome of 280 kb) were screened and 37 interacting
phage proteins were found. Eight toxic proteins were detected, of which four were also toxic in
E. coli [15]. Although toxic proteins can be discovered using this method, many toxic proteins may be
overlooked that interact with other, yet unknown, bacterial targets. To find new bacterial targets of
phage proteins, the starting point of the research should be shifted from screening bacterial targets
towards screening phage proteins.
One such method makes use of a genomic library of sheared phage genome fragments.
Singh et al. [14] generated a genomic library of seven siphoviruses with a genome of 49 to 57
kb in which the genome fragments were expressed from an inducible promoter. The clones were
screened for their toxicity in Mycobacterium smegmatis and Mycobacterium bovis. Two toxic phage
proteins, that were also toxic in E. coli, and two toxic synthetic peptides, that were encoded by artificial
ORFs, were identified [14]. The genomic fragments that are randomly cloned into plasmids may
generate artificial ORFs, with original fragments in the wrong orientation, or contain a truncated ORF.
Furthermore, some ORFs in longer inserts may not be expressed from the inducible promoter that is
present in the plasmid. As a result, there is a high chance of overlooking toxic phage proteins. A more
thorough screening assay would investigate phage ORFs individually.
Liu et al. [13] cloned all predicted genes, except for those encoding holins, amidases, and proteins
with predicted transmembrane domains, of 27 Staphylococcus phages individually into plasmids
under the expression of an inducible promoter. The toxicity of the phage proteins was screened in
Staphylococcus. In one of the phages, a siphovirus with a genome of approximately 42 kb, three toxic
proteins were detected. In all 27 phages together (964 ORFs), 31 novel toxic protein families were
found. Highly related proteins, which belong to the same family, were found in several phages [13].
We believe that the method used by Liu et al. [13] is very suitable for detecting all toxic proteins
encoded by phages. There may, however, be a slightly more efficient way of screening all genes of
phages that does not require the purification of plasmids and uses methods to exclude certain genes
from the screening assay.
In the approach used previously by our group, we excluded both gene products with a predicted
function and virion-associated (structural) proteins from the screen, since both types of proteins are
unlikely to be toxic via novel mechanisms [17]. The selected HPUF genes of the 169 kb myovirus
ϕR1-RT were cloned into plasmids and the ligation mixtures were used as such in the initial screening
assay to transform E. coli bacteria. The toxicity of proteins in the initial assay, recorded as a lower
plating efficiency, was confirmed in a follow-up assay in which the candidate genes were cloned
into the plasmid pBAD30 under the expression of an inducible promoter. Four toxic proteins were
found in the genome of this phage [17]. Characterization of the toxic mechanisms of those proteins
is undergoing.
In the present work, the HPUFs of fHe-Kpn01 were screened following the above-described
strategy [17] with some modifications in the initial screening assay to obtain a more robust assay.
During the optimization of the initial screening assay, we found that variation occurs in several stages of
the assay (Figure 4 and Table S5). First of all, many pipetting steps are used during the assay. Secondly,
the assay utilizes electroporation, which is rarely used during a quantitative assay. Moreover, although
the use of unpurified ligation mixtures saves time, it may also introduce some unwanted plasmids
into the bacteria, causing variation between ligation mixtures of the same gene. Furthermore, only
limited amounts of electrocompetent cells could be made in one batch and therefore several batches
of cells with slightly different transformation efficiencies were used. However, by using E. coli as
the primary screening host, high quality cells could be obtained for the electroporation of crude ligation
mixtures with comparable efficiencies. In addition, variation could occur in the spreading and growth
of the bacteria on plates, possibly resulting in variation in CFU counts even between replicates
from a single transformation experiment. Lastly, only a limited amount of electroporations could be
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performed at the same time to ensure equal treatment of all tested genes. Generally, we performed
eight electroporations at the same time, which included six HPUFs, the toxic control, and the non-toxic
control. The amount of CFUs of the non-toxic control Gp178 seemed to be the most stable factor during
all electroporations. Therefore, the CFU numbers were normalized relative to the CFU numbers of
Gp178 in each batch of electroporations. Despite the different sources of variation during the initial
screening assay, we obtained reliable results by using two biological replicates and three plates per
electroporation. The five HPUF proteins showing the lowest relative transformation efficiencies
(Figure 4) were tested in a second assay that confirmed the toxicity of three of the proteins (Figure 5).
Considering the studies that have been performed previously and the genome sizes of the phages
screened in those studies, it is likely that we found most of the toxic proteins of fHe-Kpn01.
The discovery of completely new toxic proteins can provide novel insights into bacterial targets
and mechanisms of toxicity. The first step in investigating the discovered toxic proteins in more
detail was carried out in silico by investigating whether structural domains of the proteins could
be predicted. While no structural elements could be predicted for Gp10 and Gp38, the structure of
Gp22 was found to be related to tRNA nucleotidyltransferases, also called 3’-terminal CCA-adding
enzymes, of several species. Nucleotidyltransferases are part of a big superfamily of proteins that
stretches over archaea, bacteria, and eukaryotes. Proteins in this superfamily contain a common core
fold and several conserved catalytic residues, but often little sequence similarity is found between
different members of this superfamily [70]. The proteins belonging to this family are involved in
nearly all cellular processes, including transcription, translation, regulation of protein activity, DNA
repair, RNA editing, cell signaling, and cell death [71,72]. Common sequence patterns are found
in distinct members of this superfamily, including tRNA nucleotidyltransferases [71]. Interestingly,
these sequence patterns are also found in the sequence of Gp22, starting at amino acid 29 (hG[GS]),
44 ([DE]h[DE]h) and 114 (h[DE]h), in which h indicates a hydrophobic amino acid. The latter two
patterns contain the catalytic residues [71] and are located in the highly conserved beta-sheet region of
these types of proteins [73]. All in all, it is possible that Gp22 functions as a nucleotidyltransferase.
The mechanism by which Gp22 exerts its toxicity is, however, unclear since these proteins are involved
in many different cellular processes.
The next step in the exploitation of the toxic character of Gp10, Gp22, and Gp38 requires in-depth
characterization of their mechanisms of toxicity. Investigating the toxicity of the proteins in both
gram-negative and -positive bacteria could indicate whether conserved host protein complexes are
targeted [14]. To examine the toxicity in different host cells, one should consider using shuttle vectors
or, alternatively, Gateway vectors for trivial cloning steps. We have used E. coli as a screening host
for toxic proteins of Yersinia [17] and Klebsiella (in this work) phages, reasoning that the hits would
cross the species- and genus-barriers thus making the new targets more universal. Identification
of the protein-protein-interaction networks of the toxic proteins would require the production
and purification of affinity-tagged proteins. This could be challenging in bacteria as the proteins
are toxic. However, an in vitro transcription-translation approach could be used. Subsequently,
the proteins could be structurally and biophysically characterized and their bacterial targets could
be elucidated. Smaller peptides with better solubility could be synthesized from the toxic proteins
to investigate their antibacterial properties. In addition, the bacterial targets could be used to screen
synthetic compound libraries for small molecules that can mimic the effect of the phage proteins [13].
Ultimately, the discovery of the three toxic proteins of fHe-Kpn01 could lead to the development of
new antibiotics.
In summary, we isolated and characterized the novel Klebsiella phage fHe-Kpn01. By systematically
screening the HPUFs encoded in the genome, we identified three toxic proteins, which opens up
opportunities for the development of innovative antibiotics.
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/12/5/544/s1,
Figure S1: Restriction enzyme digestion analysis of fHe-Kpn01 DNA, Figure S2: Determination of the physical
ends of the fHe-Kpn01 genome, Figure S3: Detection of nicks in the genome of fHe-Kpn01, Figure S4:
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Transmission electron micrograph of a negatively stained fHe-Kpn01 particle, Figure S5: Plaque morphology of
K. pneumoniae #5504 infected by fHe-Kpn01, Figure S6: Alignment of the receptor binding proteins of the fHe-Kpn01
and vB_KpnP_SU503 phages, Table S1: Bacterial strains used to determine the host range of fHe-Kpn01, Table S2:
The predicted gene products of fHe-Kpn01, Table S3: Primers used to amplify the HPUF genes from fHe-Kpn01,
Table S4: Genome typing analysis of representative K. pneumoniae strains carried out with the Kleborate tool,
Table S5: CFU counts relative to the CFU of Gp178 in that batch of electroporations.
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